Personal or family history of medullary thyroid carcinoma (MTC): As with other GLP-1 receptor agonists, caution is advised in individuals with a history of MTC or Multiple Endocrine Neoplasia syndrome type 2, due to theoretical risk associations
The monthly price for commercially insured patients, meanwhile, could potentially run as low as $25 for those using savings plans, Novo said in a press release
Mechanistically, even small stimulation of GLP-1 receptors can: Reduce hunger and cravings, making it easier to stick to a reduced-calorie eating pattern Smooth out blood sugar spikes after meals, which may reduce energy crashes and rebound hunger Support improvements in weight-related markers such as HbA1c, especially when combined with lifestyle changes However, it is important to be clear about the evidence
That said, the most expensive option is not automatically the best
Compounded medications do not undergo pre-market review or an FDA-approval process
FDA-approved oral GLP-1 tablets Rybelsus is the most well-known FDA-approved oral semaglutide